LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 18 of 497
Next
>>
>
426 to 450 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	XMD16-144	0.12	uM	LJP5	3	M11	72	hr	1097	1471	3769	0.3902	0.1399
BT-20	Brivanib	0.12	uM	LJP5	1	P17	72	hr	1097	3273	3769	0.8683	0.8142
BT-20	Brivanib	0.12	uM	LJP5	2	P17	72	hr	1097	3763	3769	0.9983	0.9976
BT-20	Brivanib	0.12	uM	LJP5	3	P17	72	hr	1097	3667	3769	0.9728	0.9616
BT-20	Buparlisib	0.12	uM	LJP5	1	H05	72	hr	1097	2929	3769	0.7770	0.6855
BT-20	Buparlisib	0.12	uM	LJP5	2	H05	72	hr	1097	2903	3769	0.7701	0.6757
BT-20	Buparlisib	0.12	uM	LJP5	3	H05	72	hr	1097	3223	3769	0.8550	0.7955
BT-20	BX-912	0.12	uM	LJP5	1	L23	72	hr	1097	3457	3769	0.9171	0.8830
BT-20	BX-912	0.12	uM	LJP5	2	L23	72	hr	1097	3505	3769	0.9298	0.9010
BT-20	BX-912	0.12	uM	LJP5	3	L23	72	hr	1097	4160	3769	1.1036	1.1461
BT-20	Canertinib	0.12	uM	LJP6	1	H11	72	hr	1097	3265	3769	0.8662	0.8112
BT-20	Canertinib	0.12	uM	LJP6	2	H11	72	hr	1097	3343	3769	0.8869	0.8404
BT-20	Canertinib	0.12	uM	LJP6	3	H11	72	hr	1097	3213	3769	0.8524	0.7917
BT-20	Celastrol	0.12	uM	LJP6	1	G11	72	hr	1097	4151	3769	1.1012	1.1427
BT-20	Celastrol	0.12	uM	LJP6	2	G11	72	hr	1097	3901	3769	1.0349	1.0492
BT-20	Celastrol	0.12	uM	LJP6	3	G11	72	hr	1097	3753	3769	0.9956	0.9938
BT-20	CGP60474	0.12	uM	LJP5	1	F05	72	hr	1097	766	3769	0.2032	-0.1240
BT-20	CGP60474	0.12	uM	LJP5	2	F05	72	hr	1097	988	3769	0.2621	-0.0409
BT-20	CGP60474	0.12	uM	LJP5	3	F05	72	hr	1097	1043	3769	0.2767	-0.0203
BT-20	CGP60474	0.12	uM	LJP6	1	G05	72	hr	1097	656	3769	0.1740	-0.1651
BT-20	CGP60474	0.12	uM	LJP6	2	G05	72	hr	1097	680	3769	0.1804	-0.1561
BT-20	CGP60474	0.12	uM	LJP6	3	G05	72	hr	1097	654	3769	0.1735	-0.1659
BT-20	CHIR-99021	0.12	uM	LJP6	1	P17	72	hr	1097	3306	3769	0.8770	0.8265
BT-20	CHIR-99021	0.12	uM	LJP6	2	P17	72	hr	1097	3019	3769	0.8009	0.7191
BT-20	CHIR-99021	0.12	uM	LJP6	3	P17	72	hr	1097	3438	3769	0.9121	0.8759

|<
<<
Previous
Page 18 of 497
Next
>>
>
426 to 450 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)